In vivo, the activation of nuclear factor erythroid 2-related factor 2 (NRF2) by sulforaphane (SFN) alleviated the progression of DCM by inhibiting myocardial cell ferroptosis [119]. This evidence concerns the gene NFE2L2 and familial dilated cardiomyopathy.